Published in Surgery on October 01, 2009
Survival of recipients of livers from donation after circulatory death who are relisted and undergo retransplant for graft failure. Am J Transplant (2014) 2.67
Biliary complications after liver transplantation from donation after cardiac death donors: an analysis of risk factors and long-term outcomes from a single center. Ann Surg (2011) 1.98
A comprehensive risk assessment of mortality following donation after cardiac death liver transplant - an analysis of the national registry. J Hepatol (2011) 1.94
Donation after cardiac death: a 29-year experience. Surgery (2011) 1.18
Superior survival using living donors and donor-recipient matching using a novel living donor risk index. Hepatology (2014) 1.12
Ischemia-Reperfusion Injury and Ischemic-Type Biliary Lesions following Liver Transplantation. J Transplant (2012) 1.09
Comparative effectiveness of donation after cardiac death versus donation after brain death liver transplantation: Recognizing who can benefit. Liver Transpl (2012) 1.08
Minimising cold ischaemic time is essential in cardiac death donor-associated liver transplantation. HPB (Oxford) (2011) 0.84
Management of biliary complications in the liver transplant patient. Gastroenterol Hepatol (N Y) (2010) 0.81
Aetiology and risk factors of ischaemic cholangiopathy after liver transplantation. World J Gastroenterol (2014) 0.80
Expanded criteria donors. Clin Liver Dis (2014) 0.79
Donation after cardio-circulatory death liver transplantation. World J Gastroenterol (2012) 0.78
NUTORC-a transdisciplinary health services and outcomes research team in transplantation. Transl Behav Med (2012) 0.78
Potential approaches to improve the outcomes of donation after cardiac death liver grafts. World J Transplant (2016) 0.75
Dual chamber stent prevents organ malperfusion in a model of donation after cardiac death. Surgery (2016) 0.75
Endoscopic management of biliary complications following liver transplantation after donation from cardiac death donors. Can J Gastroenterol (2012) 0.75
Donor preoperative oxygen delivery and post-extubation hypoxia impact donation after circulatory death hypoxic cholangiopathy. World J Gastroenterol (2016) 0.75
Radiologic Characterization of Ischemic Cholangiopathy in Donation-After-Cardiac-Death Liver Transplants and Correlation With Clinical Outcomes. AJR Am J Roentgenol (2015) 0.75
Clinical outcomes and quality of life in recipients of livers donated after cardiac death. Gastroenterol Res Pract (2015) 0.75
Timing of hepatic artery reperfusion and biliary strictures in liver transplantation. J Transplant (2013) 0.75
Characteristics associated with liver graft failure: the concept of a donor risk index. Am J Transplant (2006) 8.03
Liver transplantation from controlled non-heart-beating donors: an increased incidence of biliary complications. Transplantation (2003) 2.63
Risk factors for graft survival after liver transplantation from donation after cardiac death donors: an analysis of OPTN/UNOS data. Am J Transplant (2006) 2.47
Liver and intestine transplantation in the United States, 1997-2006. Am J Transplant (2008) 2.04
Survival following liver transplantation from non-heart-beating donors. Ann Surg (2004) 1.96
Experience with liver and kidney allografts from non-heart-beating donors. Transplantation (1995) 1.83
Donation after cardiac death: the University of Wisconsin experience with liver transplantation. Ann Surg (2005) 1.67
Donation after cardiac death as a strategy to increase deceased donor liver availability. Ann Surg (2006) 1.66
Successful extrarenal transplantation from non-heart-beating donors. Transplantation (1995) 1.53
Biliary complications and outcomes of liver transplantation from donors after cardiac death. Liver Transpl (2007) 1.50
Utilization, outcomes, and retransplantation of liver allografts from donation after cardiac death: implications for further expansion of the deceased-donor pool. Ann Surg (2008) 1.49
Ischemic cholangiopathy following liver transplantation from donation after cardiac death donors. Liver Transpl (2008) 1.36
Short- and long-term outcomes with the use of kidneys and livers donated after cardiac death. Am J Transplant (2006) 1.27
Solving the organ shortage crisis: the 7th annual American Society of Transplant Surgeons' State-of-the-Art Winter Symposium. Am J Transplant (2008) 1.21
Donation after cardiac death: the University of Wisconsin experience. Ann Transplant (2004) 1.14
Factors affecting graft survival after liver transplantation from donation after cardiac death donors. Transplantation (2006) 1.14
Controlled non-heart-beating donor liver transplantation: a successful single center experience, with topic update. Transplantation (2000) 1.13
Long-term outcome of controlled, non-heart-beating donor liver transplantation. Transplantation (2004) 1.04
Who pays for biliary complications following liver transplant? A business case for quality improvement. Am J Transplant (2006) 1.03
Medicare and Medicaid programs; conditions for coverage for organ procurement organizations (OPOs). Final rule. Fed Regist (2006) 1.02
Liver transplantation from donation after cardiac death: a single center experience. Transplantation (2007) 1.00
Histidine-Tryptophan-Ketoglutarate (HTK) is associated with reduced graft survival in deceased donor livers, especially those donated after cardiac death. Am J Transplant (2008) 0.95
Ischemic cholangiopathy. J Hepatol (2006) 0.94
Clinical results of an organ procurement organization effort to increase utilization of donors after cardiac death. Transplantation (2006) 0.91
Ischemic cholangiopathy after liver transplantation from controlled non-heart-beating donors-a single-center experience. Transplant Proc (2007) 0.89
The impact of donor variables on the outcome of orthotopic liver transplantation for hepatitis C. Transplant Proc (2008) 0.87
Directing surgical quality improvement initiatives: comparison of perioperative mortality and long-term survival for cancer surgery. J Clin Oncol (2008) 2.74
Pediatric nurses' beliefs and pain management practices: an intervention pilot. West J Nurs Res (2010) 2.73
Improvement in survival associated with adult-to-adult living donor liver transplantation. Gastroenterology (2007) 2.72
Measuring the significance of field validation in the College of American Pathologists Interlaboratory Comparison Program in Cervicovaginal Cytology: how good are the experts? Arch Pathol Lab Med (2005) 2.69
Outcomes of 385 adult-to-adult living donor liver transplant recipients: a report from the A2ALL Consortium. Ann Surg (2005) 2.64
Physical activity participation among persons with disabilities: barriers and facilitators. Am J Prev Med (2004) 2.48
Radioembolization results in longer time-to-progression and reduced toxicity compared with chemoembolization in patients with hepatocellular carcinoma. Gastroenterology (2010) 2.35
Autologous options for postmastectomy breast reconstruction: a comparison of outcomes based on the American College of Surgeons National Surgical Quality Improvement Program. J Am Coll Surg (2012) 2.20
State of the art in trueness and interlaboratory harmonization for 10 analytes in general clinical chemistry. Arch Pathol Lab Med (2008) 2.15
Insulin glargine versus sitagliptin in insulin-naive patients with type 2 diabetes mellitus uncontrolled on metformin (EASIE): a multicentre, randomised open-label trial. Lancet (2012) 2.13
Liver transplant recipient survival benefit with living donation in the model for endstage liver disease allocation era. Hepatology (2011) 2.01
A comprehensive risk assessment of mortality following donation after cardiac death liver transplant - an analysis of the national registry. J Hepatol (2011) 1.94
Patient outcomes for segmental colon resection according to surgeon's training, certification, and experience. Surgery (2002) 1.81
Applying multimedia design principles enhances learning in medical education. Med Educ (2011) 1.80
Creatinine measurement: state of the art in accuracy and interlaboratory harmonization. Arch Pathol Lab Med (2005) 1.77
Yttrium-90 microspheres (TheraSphere) treatment of unresectable hepatocellular carcinoma: downstaging to resection, RFA and bridge to transplantation. J Surg Oncol (2006) 1.68
Focal endoscopic mucosal resection before radiofrequency ablation is equally effective and safe compared with radiofrequency ablation alone for the eradication of Barrett's esophagus with advanced neoplasia. Gastrointest Endosc (2012) 1.67
Aurora B kinase phosphorylates and instigates degradation of p53. Proc Natl Acad Sci U S A (2012) 1.66
Laboratory test results after living liver donation in the adult-to-adult living donor liver transplantation cohort study. Liver Transpl (2011) 1.59
Beta-adrenoceptor agonists stimulate endothelial nitric oxide synthase in rat urinary bladder urothelial cells. J Neurosci (2002) 1.58
Barriers associated with exercise and community access for individuals with stroke. J Rehabil Res Dev (2008) 1.57
Distribution of the tight junction proteins ZO-1, occludin, and claudin-4, -8, and -12 in bladder epithelium. Am J Physiol Renal Physiol (2004) 1.57
Stretch-regulated exocytosis/endocytosis in bladder umbrella cells. Mol Biol Cell (2002) 1.56
Chemoembolization for hepatocellular carcinoma: comprehensive imaging and survival analysis in a 172-patient cohort. Radiology (2010) 1.55
Resident involvement and plastic surgery outcomes: an analysis of 10,356 patients from the American College of Surgeons National Surgical Quality Improvement Program database. Plast Reconstr Surg (2013) 1.54
Outcomes of patients with hepatitis C undergoing simultaneous liver-kidney transplantation. J Hepatol (2009) 1.50
Colonoscopic diagnosis of mucocele of the appendix. Gastrointest Endosc (2005) 1.49
Kidney transplant candidates' understanding of increased risk donor kidneys: a qualitative study. Clin Transplant (2011) 1.48
Early Postoperative Emergency Department Care of Abdominal Transplant Recipients. Transplantation (2015) 1.48
Demographic, psychosocial, and behavioral factors associated with survival after heart transplantation. Ann Thorac Surg (2013) 1.48
Crosstalk between mast cells and pancreatic cancer cells contributes to pancreatic tumor progression. Clin Cancer Res (2010) 1.46
Successful sofosbuvir-based therapy in HIV/hepatitis C virus coinfected liver transplant recipients with recurrent hepatitis C virus infection. AIDS (2016) 1.45
Risk factors for acquiring functional and cognitive disabilities during admission to a PICU*. Pediatr Crit Care Med (2014) 1.45
Relevance of the c-statistic when evaluating risk-adjustment models in surgery. J Am Coll Surg (2012) 1.45
A model for reactivation of CMV from latency. J Clin Virol (2002) 1.43
Phenytoin overview--metabolite interference in some immunoassays could be clinically important: results of a College of American Pathologists study. Arch Pathol Lab Med (2003) 1.41
Laparoscopic donor nephrectomy 1997 to 2003: lessons learned with 500 cases at a single institution. Surgery (2004) 1.28
Age and racial/ethnic disparities in arthritis-related hip and knee surgeries. Med Care (2008) 1.26
Radiographic response to locoregional therapy in hepatocellular carcinoma predicts patient survival times. Gastroenterology (2011) 1.25
Inoculation against falls: rapid adaptation by young and older adults to slips during daily activities. Arch Phys Med Rehabil (2010) 1.24
Recruitment of African American women to a walking program: eligibility, ineligibility, and attrition during screening. Res Nurs Health (2006) 1.21
Laparoscopic-assisted vs. open colectomy for cancer: comparison of short-term outcomes from 121 hospitals. J Gastrointest Surg (2008) 1.18
Radiation lobectomy: preliminary findings of hepatic volumetric response to lobar yttrium-90 radioembolization. Ann Surg Oncol (2009) 1.17
Safety and efficacy of endoscopic mucosal therapy with radiofrequency ablation for patients with neoplastic Barrett's esophagus. Clin Gastroenterol Hepatol (2012) 1.15
The extent and predictors of waiting time geographic disparity in kidney transplantation in the United States. Transplantation (2014) 1.15
Antineoplastic effects of an Aurora B kinase inhibitor in breast cancer. Mol Cancer (2010) 1.15
Proposed classification of complications after live donor nephrectomy. Urology (2006) 1.15
Neighborhood environment and adherence to a walking intervention in African American women. Health Educ Behav (2008) 1.14
Accessibility of health clubs for people with mobility disabilities and visual impairments. Am J Public Health (2005) 1.13
Hospitalization rates before and after adult-to-adult living donor or deceased donor liver transplantation. Ann Surg (2010) 1.13
Laparoscopy-assisted and open living donor right hepatectomy: a comparative study of outcomes. Surgery (2009) 1.13
Obesity prevalence among a group of Chicago residents with disabilities. Arch Phys Med Rehabil (2005) 1.11
The increased costs of donation after cardiac death liver transplantation: caveat emptor. Ann Surg (2010) 1.11
Ischemic cholangiopathy after controlled donation after cardiac death liver transplantation: a meta-analysis. Ann Surg (2011) 1.11
Outcomes of a home-based walking program for African-American women. Am J Health Promot (2008) 1.09
Outcomes of adult living donor liver transplantation: comparison of the Adult-to-adult Living Donor Liver Transplantation Cohort Study and the national experience. Liver Transpl (2011) 1.09
Comparative effectiveness of donation after cardiac death versus donation after brain death liver transplantation: Recognizing who can benefit. Liver Transpl (2012) 1.08
Human NOTES cholecystectomy: transgastric hybrid technique. J Gastrointest Surg (2009) 1.07
Women's health issues with fibromyalgia syndrome. J Womens Health (Larchmt) (2006) 1.06
The human "Treg MLR": immune monitoring for FOXP3+ T regulatory cell generation. Transplantation (2009) 1.06
Laparoscopic liver surgery for everyone: the hybrid method. Surgery (2007) 1.05
Analytic bias of thyroid function tests: analysis of a College of American Pathologists fresh frozen serum pool by 3900 clinical laboratories. Arch Pathol Lab Med (2005) 1.04
Lack of specificity of cyclosporine immunoassays. Results of a College of American Pathologists Study. Arch Pathol Lab Med (2003) 1.04
Effect of corticosteroid therapy on outcomes in biliary atresia after Kasai portoenterostomy. J Pediatr Surg (2006) 1.03
Menopausal status, moderate-intensity walking, and symptoms in midlife women. Res Theory Nurs Pract (2005) 1.03
A review of quality of life instruments used in liver transplantation. J Hepatol (2009) 1.03
Comparison of hospital performance in nonemergency versus emergency colorectal operations at 142 hospitals. J Am Coll Surg (2009) 1.02
Increased quality of life among hepatocellular carcinoma patients treated with radioembolization, compared with chemoembolization. Clin Gastroenterol Hepatol (2013) 1.02
Risk for immune-mediated graft dysfunction in liver transplant recipients with recurrent HCV infection treated with pegylated interferon. Gastroenterology (2012) 1.01
Prospective measurements of intra-abdominal volume and pulmonary function after repair of massive ventral hernias with the components separation technique. Ann Surg (2010) 0.99
Teaching for understanding in medical classrooms using multimedia design principles. Med Educ (2013) 0.99
Aerobic exercise training in stroke survivors. Top Stroke Rehabil (2005) 0.99
Isolated gastrocnemius and soleal vein thrombosis: should these patients receive therapeutic anticoagulation? Ann Surg (2010) 0.98
The Oral Health Information Suite (OHIS): its use in the management of periodontal disease. J Dent Educ (2005) 0.97
Magnetic resonance elastography and biomarkers to assess fibrosis from recurrent hepatitis C in liver transplant recipients. Transplantation (2011) 0.97
Effects of perceived and objective neighborhood crime on walking frequency among midlife African American women in a home-based walking intervention. J Phys Act Health (2010) 0.97
Learning from laboratory-induced falling: long-term motor retention among older adults. Age (Dordr) (2014) 0.97
Obesity and overweight prevalence among adolescents with disabilities. Prev Chronic Dis (2011) 0.96
Neighborhood characteristics, adherence to walking, and depressive symptoms in midlife African American women. J Womens Health (Larchmt) (2009) 0.96
Alpha-fetoprotein response correlates with EASL response and survival in solitary hepatocellular carcinoma treated with transarterial therapies: a subgroup analysis. J Hepatol (2012) 0.96
The T-cell receptor is not hardwired to engage MHC ligands. Proc Natl Acad Sci U S A (2012) 0.95
Use of yttrium-90 microspheres (TheraSphere) in a patient with unresectable hepatocellular carcinoma leading to liver transplantation: a case report. Liver Transpl (2005) 0.95
Analysis of tumor necrosis factor-alpha, transforming growth factor-beta 1, interleukin-10, and interferon-gamma polymorphisms in patients with alcoholic chronic pancreatitis. Alcohol (2004) 0.94
Allospecific regulatory effects of sirolimus and tacrolimus in the human mixed lymphocyte reaction. Transplantation (2011) 0.93
Improvements in physical fitness in adults with Down syndrome. Am J Ment Retard (2004) 0.93
Surgical considerations in cystic fibrosis: a 32-year evaluation of outcomes. Surgery (2005) 0.92
A randomized controlled trial to increase physical activity and reduce obesity in a predominantly African American group of women with mobility disabilities and severe obesity. Prev Med (2009) 0.91
Development and validation of AIMFREE: Accessibility Instruments Measuring Fitness and Recreation Environments. Disabil Rehabil (2004) 0.91